PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-10-13

Date Title Company
13-Oct-2021 New Data up to 8-Years for Genentech’s Ocrevus (ocrelizumab) Show Early and Ongoing Treatment Significantly Reduced Risk of Requiring a Walking Aid in Relapsing Multiple Sclerosis and Disability Progression in Primary Progressive Multiple Sclerosis Businesswire
13-Oct-2021 Bicycle Therapeutics Announces Pricing of Upsized Public Offering of $175 Million of American Depositary Shares Businesswire
13-Oct-2021 Increasing Prevalence of Inflammatory Bowel Diseases to Boost Leukocytapheresis Device Market Growth: Fact.MR Report MARKITWIRED Latest Market Reports
13-Oct-2021 Growing Geriatric Population Is Expected To Drive The Demand For High Concentration Respiratory Masks, Unveils Fact.MR MARKITWIRED Latest Market Reports
13-Oct-2021 Growing Prevalence Of Osteoarthritis Will Drive Demand Of Articular Defects Treatment Market MARKITWIRED Latest Market Reports
13-Oct-2021 Technological Advancements In Veterinary Respiratory Ventilators Are Further Driving The Demand For The Product In Matured Market MARKITWIRED Latest Market Reports
13-Oct-2021 Nonerosive Reflux Disease Treatment Market to Witness Widespread Expansion during 2021-2031: Fact.MR Report MARKITWIRED Latest Market Reports
13-Oct-2021 Animal Antibiotics Market Poised to Garner Maximum Revenues during 2021-2031; Increased Demand for Dairy Products and Meat to Bolster Growth MARKITWIRED Latest Market Reports
13-Oct-2021 Diet Pills Market Expansion to be Persistent through 2021-2031; Increasing Incidences of High Blood Pressure and Type 2 Diabetes to Augment Market Growth MARKITWIRED Latest Market Reports
13-Oct-2021 Advanced Healthcare Facilities Is Likely To Create an Influx of Opportunities in the Intravascular Temperature Management System Market MARKITWIRED Latest Market Reports
13-Oct-2021 Advanced Wound Healing Market Is Expected To Reach (USD) 16.5 Billion By 2027 MARKITWIRED Latest Market Reports
13-Oct-2021 BHK Rabies Vaccine Market 2026 Statistics May Set New Growth Story In Upcoming Years MARKITWIRED Latest Market Reports
13-Oct-2021 百濟神州宣布,BRUKINSA® (Zanubrutinib)獲准用於治療被套細胞淋巴瘤患者 Businesswire
13-Oct-2021 百济神州宣布,百悦泽®(泽布替尼)获准用于治疗套细胞淋巴瘤患者 Businesswire
13-Oct-2021 百濟神州宣布,澳洲首次核准BRUKINSA® (Zanubrutinib)用於治療華氏巨球蛋白血症患者 Businesswire
13-Oct-2021 百济神州宣布,澳大利亚首次核准百悦泽®(泽布替尼)用于治疗华氏巨球蛋白血症患者 Businesswire